Jefferies Financial Group’s CureVac CVAC Stock Holding History

Jefferies Financial Group’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,258	Closed	-$61.9K	–	1690
2022 Q4	$61.9K	Buy	+10,258	New	+$75.8K	﹤0.01%	1399

Other funds holding CVAC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Jefferies Financial Group's CVAC Position: Q1 2023 in Review

Jefferies Financial Group sold out of CureVac (CVAC) in Q1 2023, closing a stake of 10,258 shares — an estimated $61.9K sold.

Jefferies Financial Group first reported a position in CVAC in Q4 2022 and held it in 1 quarter. The position peaked at $61.9K in Q4 2022. 82 funds tracked by Wall St. Rank hold CVAC as of Q1 2023.

Jefferies Financial Group reported no remaining CureVac position as of Q1 2023 after selling out during the quarter.
Jefferies Financial Group sold 10,258 CureVac shares in Q1 2023, an estimated $61.9K.
Jefferies Financial Group first reported a position in CureVac in Q4 2022 and held it in 1 quarter.
Jefferies Financial Group's CureVac position peaked at $61.9K in Q4 2022.
82 funds tracked by Wall St. Rank held CureVac as of Q1 2023.

Based on Jefferies Financial Group's 13F filing for Q1 2023, filed 15 May 2023.